Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharm-Olam
CRO
DOD taps Pharm-Olam for repurposed Humira COVID-19 test
Pharm-Olam has been handed a DOD contract to run a mid- to late-stage trial of blockbuster autoimmune and inflammation drug adalimumab.
Ben Adams
Jan 28, 2021 7:05am
BARDA taps Pharm-Olam to join its trial network
Oct 9, 2020 8:55am
Covance exec takes the reins at Pharm-Olam
Oct 14, 2019 7:22am
Chutes & Ladders—Eli Lilly vet Derica Rice to retire as CFO
Jun 1, 2017 10:38pm
INC Research and Medidata expand partnership on data technology
Mar 3, 2017 4:51pm
